InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,461.43
(
0.63%
)
US TECH 100
18,588.00
(
0.28%
)
Dow Jones
40,230.40
(
0.94%
)
Brent Oil
81.48
(
0.92%
)
Bitcoin
64,852.18
(
-0.79%
)
Post# of 4764
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 834
Posts 120114
Boards Moderated 16
Alias Born 09/05/2002

DewDiligence

Member Level

Re: topicviewer post# 826

Friday, 08/11/2006 6:11:14 PM

Friday, August 11, 2006 6:11:14 PM

Post# of 4764
>But for Elemer Piros of Rodman & Renshaw, Repligen's allure is in its products already on the market, plus others in clinical trials, such as secretin for schizophrenia…<

If Piros sincerely thinks secretin will work in schizophrenia, he must be schizophrenic himself. More likely, he is just pumping.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up